EDX Medical was proud to host an exclusive webinar: Curesponse – Personal Oncology: cResponse™ in Practice, bringing together leading experts in oncology to explore how functional testing is transforming personalised cancer care.
With attendance from across the oncology and research communities, the session highlights the power of cResponse™, a breakthrough ex vivo platform designed to assess and predict the effectiveness of single and multi-drug chemotherapy, immunotherapy, and targeted therapy on tumour tissue – in real time.
The event featured expert insights from Professor Ravid Straussman (Weizmann Institute of Science), Dr Jonathan Krell (Imperial College Healthcare NHS Trust) and was chaired by Professor Tobi Arkenau (UCL), who shared the latest evidence and clinical experience using cResponse™ to inform precision treatment strategies.
A new era of personalised oncology is here with cResponse™.
EDX Medical is the exclusive distributor of cResponse in the United Kingdom and the Nordics.
Learn more about cResponse™: https://edxmedical.co.uk/product/cresponse-functional-tumour-test/
